We are live on
!
Find out more
UOC
UBS O'Connor Portfolio holdings
AUM
$3.76B
1-Year Est. Return
62.41%
This Fund
S&P 500
This Quarter
Est. Return
+0.84%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$9.62B
AUM Growth
+$482M
(+5.3%)
Cap. Flow
+$328M
Cap. Flow
% of AUM
3.41%
Top 10 Holdings %
Top 10 Hldgs %
35.81%
Holding
1,132
New
163
Increased
147
Reduced
109
Closed
164
Avg Time Held Equity + Options
2.6
quarters
Top 10 Avg Time Held Equity + Options
0.5
quarters
Top 20 Avg Time Held Equity + Options
0.6
quarters
Avg Time Held Equity only
2.6
quarters
Top 10 Avg Time Held Equity only
0.5
quarters
Top 20 Avg Time Held Equity only
0.6
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ACC
American Campus Communities, Inc.
ACC
|
+$454M |
| 2 |
SailPoint Technologies Holdings, Inc. Common Stock
SAIL
|
+$312M |
| 3 |
CDK
CDK Global, Inc.
CDK
|
+$286M |
| 4 |
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$248M |
| 5 |
MNDT
Mandiant, Inc. Common Stock
MNDT
|
+$220M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CERN
Cerner Corp
CERN
|
+$829M |
| 2 |
MIME
Mimecast Limited
MIME
|
+$351M |
| 3 |
PLAN
Anaplan, Inc.
PLAN
|
+$325M |
| 4 |
MGP
MGM Growth Properties LLC Class A common shares representing limited liability company interests
MGP
|
+$260M |
| 5 |
VNE
Veoneer, Inc.
VNE
|
+$240M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.77% |
| 2 | Financials | 20.95% |
| 3 | Industrials | 11.05% |
| 4 | Real Estate | 10.82% |
| 5 | Healthcare | 9.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
TRCA
576
DELISTED
Twin Ridge Capital Acquisition Corp.
TRCA
| $2.51M | 0.03% |
256,126
| – | – |
2021 Q2
4 quarters
|
|
|
IAA
577
DELISTED
IAA, Inc. Common Stock
IAA
| $2.5M | 0.03% |
76,442
+16,972
| +29% | +$621K |
2022 Q1
1 quarter
|
|
578
BioCryst Pharmaceuticals
BCRX
$2.06B
| $2.5M | 0.03% |
236,327
+192,527
| +440% | +$1.99M |
2022 Q1
1 quarter
|
|
|
PSPC
579
DELISTED
Post Holdings Partnering Corporation
PSPC
| $2.5M | 0.03% |
257,374
| – | – |
2022 Q1
1 quarter
|
|
|
HCII
580
DELISTED
Hudson Executive Investment Corp. II Class A Common Stock
HCII
| $2.49M | 0.03% |
253,262
| – | – |
2021 Q1
5 quarters
|
|
|
ALCE
581
DELISTED
Alternus Clean Energy Inc
ALCE
| $2.48M | 0.03% |
+10,112
| New | +$2.49M |
2022 Q2
0 quarters
|
|
|
BSLK
582
DELISTED
Bolt Projects Holdings
BSLK
| $2.48M | 0.03% |
12,694
| – | – |
2022 Q1
1 quarter
|
|
|
WPCA
583
DELISTED
Warburg Pincus Capital Corporation I-A
WPCA
| $2.48M | 0.03% |
252,785
| – | – |
2021 Q2
4 quarters
|
|
|
PICC
584
DELISTED
Pivotal Investment Corporation III
PICC
| $2.48M | 0.03% |
252,788
| – | – |
2021 Q2
4 quarters
|
|
585
DELISTED
Metals Acquisition
MTAL
| $2.48M | 0.03% |
252,788
-316,738
| -56% | -$3.13M |
2021 Q3
3 quarters
|
|
586
VNET Group
VNET
$1.5B
| $2.46M | 0.03% |
+407,919
| New | +$2.42M |
2022 Q2
0 quarters
|
|
|
FOUN
587
DELISTED
Founder SPAC Class A Ordinary Shares
FOUN
| $2.43M | 0.03% |
241,829
| – | – |
2021 Q4
2 quarters
|
|
588
DELISTED
Revance Therapeutics, Inc.
RVNC
| $2.42M | 0.03% |
175,179
+85,179
| +95% | +$1.31M |
2022 Q1
1 quarter
|
|
589
Deere & Co
DE
$175B
| $2.41M | 0.03% |
+8,058
| New | +$2.97M |
2022 Q2
0 quarters
|
|
|
LEAP
590
DELISTED
Ribbit LEAP, Ltd.
LEAP
| $2.36M | 0.02% |
238,370
+80,892
| +51% | +$801K |
2020 Q4
6 quarters
|
|
591
DELISTED
Finnovate Acquisition Corp. Class A Ordinary Shares
FNVT
| $2.35M | 0.02% |
236,261
| – | – |
2021 Q4
2 quarters
|
|
|
DNAD
592
DELISTED
Social Capital Suvretta Holdings Corp. IV Class A Ordinary Shares
DNAD
| $2.33M | 0.02% |
239,964
| – | – |
2021 Q2
4 quarters
|
|
593
DELISTED
Cartica Acquisition Corp Class A Ordinary Shares
CITE
| $2.32M | 0.02% |
+231,637
| New | +$2.32M |
2022 Q2
0 quarters
|
|
594
Baxter International
BAX
$12.9B
| $2.31M | 0.02% |
36,038
-15,968
| -31% | -$1.16M |
2022 Q1
1 quarter
|
|
595
PBF Energy
PBF
$10.8B
| $2.29M | 0.02% |
+78,963
| New | +$2.47M |
2022 Q2
0 quarters
|
|
596
Ionis Pharmaceuticals
IONS
$7.04B
| $2.28M | 0.02% |
61,497
+42,297
| +220% | +$1.59M |
2022 Q1
1 quarter
|
|
597
DELISTED
Mersana Therapeutics
MRSN
| $2.27M | 0.02% |
19,642
+10,682
| +119% | +$1M |
2022 Q1
1 quarter
|
|
598
Palantir
PLTR
$501B
| $2.27M | 0.02% |
250,000
+25,000
| +11% | +$247K |
2021 Q1
5 quarters
|
|
599
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $2.25M | 0.02% |
61,730
+31,730
| +106% | +$1.15M |
2022 Q1
1 quarter
|
|
|
NUVA
600
DELISTED
NuVasive, Inc.
NUVA
| $2.23M | 0.02% |
45,407
+18,407
| +68% | +$987K |
2022 Q1
1 quarter
|
|
Similar funds
FNBT
ACI
RC
A
CGL
CB
JCM
MPM
UBS O'Connor's Q2 2022 Portfolio in Review
As of Q2 2022, UBS O'Connor held 1,132 positions worth $9.62B, up 5.3% from $9.14B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
UBS O'Connor deployed $328M of net new capital in Q2 2022, opening 163 new positions and adding to 147 existing holdings. Its largest new stake was American Campus Communities, Inc.: 7,174,697 shares worth $463M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 30% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Occidental Petroleum Corp Warrants, an estimated $15.7M trimmed.
- UBS O'Connor's largest Q2 2022 buy was American Campus Communities, Inc.: 7,174,697 shares worth $463M.
- UBS O'Connor added most to Mandiant, Inc. Common Stock in Q2 2022, an estimated $220M increase.
- UBS O'Connor's biggest Q2 2022 reduction was Occidental Petroleum Corp Warrants, cutting an estimated $15.7M.
- UBS O'Connor fully exited Cerner Corp in Q2 2022, selling an estimated $829M.
- UBS O'Connor's ten largest holdings make up 36% of its $9.62B portfolio in Q2 2022.
- UBS O'Connor opened 163 new positions and closed 164 in Q2 2022.
- UBS O'Connor's portfolio value rose 5.3% quarter-over-quarter to $9.62B.
Based on UBS O'Connor's 13F filing for Q2 2022, filed 12 Aug 2022.